Lab Automation in Genomics Market by Equipment [Automated Plate Handlers, Vision Systems, Automated Storage and Retrieval Systems, Automated Liquid Handlers, and Robotic Arms], End-users [Hospitals and Private Laboratories, Environmental Testing Laboratories, Academic and Research Institutes, Biotechnology and Pharmaceutical Companies, and Forensic Laboratories], and Regions [Asia Pacific, North America, Latin America, Europe, and Middle East and Africa] – Global Industry Analysis, Growth, Shares, Size, Trends, and Forecast 2023 – 2031
Lab Automation in Genomics Market Outlook 2031
The global lab automation in genomics market size was valued at USD 5.43 Billion in 2022 and is projected to reach USD 9.21 Billion by 2031, expanding at a CAGR of 6.05% during the forecast period, 2023–2031. Growth of the market is attributed to increasing investment in genomic and drug discoveries, need for consistency in quality, and availability of cheap resources and labors.
The genomics is an associative field of biology focusing on the editing, function, mapping, evolution, and structure of genomes. A genome is an overall set of DNAs, containing all genes. The lab automation is an integrative approach to optimize, capitalize, develop, and research on technologies in the laboratory that permit improved and new operations. The functions of technology in laboratories are essential to accomplish timely development and to stay competitive.
The Covid-19 pandemic affected the demand and supply of the lab automation in genomics market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
Lab Automation in Genomics Market Trends, Drivers, Restraints, and Opportunities
- Increasing expenditure on development and research is projected to boost the market.
- High return on investment is the major factor fueling the market in the coming years.
- Lack of planning for technological development is projected to restrict the market expansion.
- High initial setup cost is anticipated to hamper the market growth during the forecast period.
- R&D investment and technological advancement in lab automation in genomics market is projected to offer lucrative opportunities for the market players.
Scope of Lab Automation in Genomics Market Report:
The report on the lab automation in genomics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Lab Automation in Genomics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016-2021 |
Forecast Period |
2023-2031 |
Segmentation |
Equipment [Automated Plate Handlers, Vision Systems, Automated Storage and Retrieval Systems, Automated Liquid Handlers, and Robotic Arms], End-users [Hospitals and Private Laboratories, Environmental Testing Laboratories, Academic and Research Institutes, Biotechnology and Pharmaceutical Companies, and Forensic Laboratories] |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East and Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players covered in the Report |
PerkinElmer Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Tecan Group Ltd, Becton Dickinson, Honeywell International, Danaher Corporation, Synchron Lab Automation, Hudson Robotics, Inc., Eppendorf AG, and Agilent Technologies Inc. |
Lab Automation in Genomics Market Segment Insights
Equipments Segment Analysis
Based on equipment’s, the lab automation in genomics market is segregated into automated plate handlers, vision systems, automated storage and retrieval systems, automated liquid handlers, and robotic arms. The automated liquid handlers segment is projected to expand at a high CAGR during the forecast period.
Growth of the market is attributed to increasing investment in genomic market and drug discoveries, and need for consistency in quality. However, the robotic arm segment is anticipated to expand at a rapid pace during the forecast period due to factors such as rapidly growing demand for personal genomics, high return on investment, and strict regulations for healthcare.
End-users Segment Analysis
On the basis of end-users, the lab automation in genomics market is fragmented into hospitals and private laboratories, environmental testing laboratories, academic and research institutes, biotechnology and pharmaceutical companies, and forensic laboratories.
The biotechnology and pharmaceutical companies segment is anticipated to expand at robust CAGR during the forecast period. The robotic arm segment is projected to expand at a rapid pace during the forecast period due to factors such as increasing expenditure on development and research, improving healthcare infrastructure across emerging countries, and high return on investment.
Regional Analysis
On the basis of regions, the lab automation in genomics market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East and Africa. The market of Asia Pacific is anticipated to expand at a high CAGR during the forecast period due to factors such as rapidly growing demand for personal genomics, high return on investment, and strict regulations for healthcare.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Lab Automation in Genomics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Lab Automation in Genomics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Lab Automation in Genomics Market - Supply Chain
4.5. Global Lab Automation in Genomics Market Forecast
4.5.1. Lab Automation in Genomics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Lab Automation in Genomics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Lab Automation in Genomics Market Absolute $ Opportunity
5. Global Lab Automation in Genomics Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Lab Automation in Genomics Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Lab Automation in Genomics Demand Share Forecast, 2019-2026
6. North America Lab Automation in Genomics Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Lab Automation in Genomics Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Lab Automation in Genomics Demand Share Forecast, 2019-2026
7. Latin America Lab Automation in Genomics Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Lab Automation in Genomics Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Lab Automation in Genomics Demand Share Forecast, 2019-2026
8. Europe Lab Automation in Genomics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Lab Automation in Genomics Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Lab Automation in Genomics Demand Share Forecast, 2019-2026
9. Asia Pacific Lab Automation in Genomics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Lab Automation in Genomics Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Lab Automation in Genomics Demand Share Forecast, 2019-2026
10. Middle East & Africa Lab Automation in Genomics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Lab Automation in Genomics Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Lab Automation in Genomics Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Lab Automation in Genomics Market: Market Share Analysis
11.2. Lab Automation in Genomics Distributors and Customers
11.3. Lab Automation in Genomics Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. PerkinElmer Inc.
11.4.2. Siemens Healthineers AG
11.4.3. Thermo Fisher Scientific Inc.
11.4.4. Tecan Group Ltd
11.4.5. Becton Dickinson